Clinical Trial Update: The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for the TRIBECA study evaluating TRIessence and Byqlovi for easier cataract surgery; recruitment is not yet underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Byqlovi
• TRIessence

Snippet

Sponsor: Research Insight LLC | Conditions: Post Cataract Surgery | Phase 4 | Status: NOT_YET_RECRUITING